Recently, Pulin Chengshan (Cayman) Holdings Co., Ltd. submitted an IPO prospectus to the Hong Kong Stock Exchange for the listing of the Main Board and BOC International Asia Limited as its sole sponsor.
In the listing application, the company detailed its business, product advantages, and multiple risks in its operations.
The company said that it has a strict quality management system and production management system, is committed to technological innovation, has a senior, stable management team, and has been supported by China National Heavy Duty Truck.
In addition to China, its products are sold to more than 130 countries through about 150 dealers, and sales in the supporting market and replacement tire market are very strong.
In addition, Pulin Chengshan highlighted that fluctuations in raw material prices may have a material adverse effect on its business, financial and operating results.
Regarding the future strategy, the company proposed the following five points:
First, strengthen its position in the all-steel radial tire market and continue to expand its business in this area;
Second, enhance global influence and grasp the growing opportunities in the tire industry;
Third, increase brand portfolio, brand awareness and brand influence;
Fourth, strengthen research and development capabilities and carry out technical reserves;
Fifth, take environmental protection measures and upgrade production equipment and processes.
It is understood that Pulin Chengshan (Shandong) Tire Co., Ltd. is an indirect wholly-owned subsidiary of Pulin Chengshan (Cayman) Holdings Co., Ltd.
Subsequently, the company acquired 100% of Hong Kong Pulin Investment Co., Ltd. for US$75,000 and assumed all of its assets and liabilities.
Blood Plasma Products,Blood Products,Human Rabies Immunoglobulin,Viral Infection
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. , https://www.syimmunoglobulin.com